This week: Healthcare AI explodes with 38.5% market growth while paradoxically “deskilling” providers, as the Trump administration’s vaccine policy reversals and MAHA initiative pivot spark scientific controversy.
This week: Prasad does the Hokey Pokey at CBER as MAHA continues to take root across federal programs.
This Week: From Medicare’s potential $2.5 billion in savings through service cuts and the FDA’s leadership exodus to NIH funding slashed to just 4% of applications and Trump’s drug pricing ultimatum, seismic policy shifts and financial upheavals are reshaping every corner of America’s healthcare landscape.
House subcommittees unite on bipartisan reform push after hearing reveals widespread insurance company abuses
This Week: It’s HOT!
This Week: CMS publishes awaited payment rules and CBO publishes estimates on the impact of NIH and FDA cuts on drug innovation.
This Week: Kennedy weighs in on prevention and vaccines, more BBB and Prior Auth news, and FDA opens the vault on its drug decisions.
This Week: Fireworks and the Big Beautiful Bill
This Week: The Big Beautiful Bill, More Vaccine Drama… and a July 4th Recess
This week: The FDA has launched a new voucher program to fast-track drug approvals for companies addressing national health priorities, aiming to lower costs, boost domestic manufacturing, and accelerate innovation.
Savage Health Policy
csavage@shpconsulting.llc
(276) 221-8300
Please provide your contact information below and we will reply to you shortly.
Recent Comments